Even if you feel fine after exposure to someone with COVID-19, you could still contract the infection.
Do the following after coming in contact with someone who has COVID-19:
Find out where and when to take a test by calling your doctor or the COVID-19 hotline.
Support contact-tracing techniques to halt the virus’s propagation.
If testing is not accessible, spend the next 14 days alone at home.
You should avoid going to work, school, or public areas while you are under quarantine. Request that someone bring you supplies.
Maintain a 1-meter minimum separation from everyone, even your family.
If/when you need to seek medical attention, protect others by donning a medical mask.
Always wash your hands.
If it’s not possible, stay in a separate room from your family and put on a mask.
Keep the space adequately ventilated.
Beds should be at least one metre apart if you are sharing a room.
For 14 days, keep an eye out for any signs.
Stay upbeat by exercising at home and staying in touch with family and friends by phone or internet.
If you develop a fever and reside in a region where dengue fever or malaria are prevalent, get medical attention. Wear a mask when going to and from the medical institution, and when receiving treatment. Maintain at least one metre distance from other people, and refrain from touching anything with your hands. Both youngsters and adults can use this.
How long does it take for COVID-19 symptoms to appear?
Between the period of exposure to COVID-19 and the onset of symptoms, which can take anywhere between 1 and 14 days, the typical time is 5 to 6 days.
In order to stop the spread of the virus, especially in areas where testing is difficult to come by, it is urged that those who have been exposed to the virus stay at home and avoid contact with others for 14 days.
Is COVID-19 a vaccine-eligible infection?
Yes. The first mass vaccination campaign began in early December 2020, and this page is updated each day with the total number of doses given. Four separate platforms have received at least 13 different vaccinations. There are now active campaigns in 206 economies.
On December 31, 2020, the Pfizer/BioNtech Comirnaty vaccine joined WHO Emergency Use Listing (EUL). Then on February 16, EUL added SII/Covishield and AstraZeneca/AZD1222 vaccines (designed by AstraZeneca/Oxford and produced by the Serum Institute of India and SK Bio, respectively). On March 12, 2021, Johnson & Johnson’s Janssen/Ad26.COV 2.S joined EUL. Both the Moderna COVID-19 vaccine (mRNA 1273) and the Sinopharm COVID-19 vaccine joined EUL on April 30 and May 7, respectively. Beijing Bio-Institute of Biological Products Co Ltd, a division of China National Biotec Group, is the company that makes the Sinopharm vaccine (CNBG).
Vaccines are first proven to be both effective and safe. Then the national regulators approve the licenses and approve the production with stringent standards, and distribution. In order to coordinate important milestones in this process, including facilitating fair access to COVID-19 vaccinations for the billions of people who will require them, WHO is collaborating with partners around the world.